Carr Patricia's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Mar 3, 2025
- Accession no.
- 0001765581-25-000010
- Filed
- Mar 3, 2025
- Trade date
- Feb 27-28, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $805.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carr PatriciaCIK 0001784606 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Ordinary Shares | MOption exerciseAcquired | +4,500 | $113.10 | +$508,950 | 12,737 | Direct | |
| Feb 27, 2025 | Ordinary Shares | SSaleDisposed | −4,500 | $144.42 | −$649,890 | 8,237 | Direct | |
| Feb 27, 2025 | Ordinary Shares | MOption exerciseAcquired | +313 | $123.36 | +$38,611.68 | 8,550 | Direct | |
| Feb 27, 2025 | Ordinary Shares | SSaleDisposed | −313 | $144.42 | −$45,203.46 | 8,237 | Direct | |
| Feb 27, 2025 | Ordinary Shares | DReturned to the companyDisposed | −371 | $142.43 | −$52,841.53 | 7,866 | Direct | |
| Feb 27, 2025 | Ordinary Shares | DReturned to the companyDisposed | −497 | $142.43 | −$70,787.71 | 7,369 | Direct | |
| Feb 27, 2025 | Ordinary Shares | AGrant or awardAcquired | +2,889 | $0.00 | $0 | 10,258 | Direct | |
| Feb 28, 2025 | Ordinary Shares | SSaleDisposed | −773 | $143.30 | −$110,770.9 | 9,485 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Ordinary Shares | MOption exerciseDisposed | −4,500 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2025 | Ordinary Shares | MOption exerciseDisposed | −313 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.